Cryoport, Inc. CYRX
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- +80.10%
- 1 year
- +92.11%
- Open
- 17.94
- Prev close
- 18.29
- Mkt cap
- 875.72M
- Vol
- 1.04M
- Avg vol
- 671.67K
- EPS
- -0.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.14
- High
- 18.25
- Forward P/E
- -7.93
- Beta
- 1.63
- Short ratio
- 4.97
- Inst. own
- 102.81%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.39
- 200-d avg
- 10.24
- 1y target
- 11.30
5D chart
Signals (92)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 11:25 AM | 2 days ago |
| RSI: Oversold | Oct 30, 11:25 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:15 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:10 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:40 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:40 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 4:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:15 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:40 AM | 6 days ago |
News
3 days ago seekingalpha.com
Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells
We remain encouraged by the operational performance of the Micro cap companies held in portfolios. TWST shares surged as a strong fiscal 3Q highlighted accelerating demand across several of the…
1 week ago prnewswire.com
Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
NASHVILLE, Tenn., Oct. 22, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for…
2 weeks ago benzinga.com
CryoPort Q2 2026 Earnings Call Transcript
CryoPort (NASDAQ:CYRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time…
-
2 weeks ago benzinga.com
BTIG Maintains Buy on CryoPort, Raises Price Target to $26
BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $25 to $26.
1 month ago zacks.com
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
-
1 month ago benzinga.com
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $16 to $19.
1 month ago seekingalpha.com
Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
Cryoport, Inc., rated BUY, is up 82% YTD, driven by robust cell and gene therapy (CGT) commercialization and pipeline momentum. CYRX returned to adjusted EBITDA profitability in 2Q26, with strong…
2 months ago zacks.com
CryoPort (CYRX) Upgraded to Buy: Here's Why
CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2 months ago seekingalpha.com
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $16.
-
2 months ago benzinga.com
Needham Maintains Buy on CryoPort, Raises Price Target to $19
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $19.
2 months ago marketbeat.com
CryoPort Q2 Earnings Call Highlights
CryoPort NASDAQ: CYRX reported second-quarter 2026 revenue of $49 million and said it reached positive adjusted EBITDA from continuing operations, while reaffirming its full-year revenue outlook of…
2 months ago zacks.com
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.29 per share a year ago.
-
2 months ago benzinga.com
Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M Est
CryoPort (NASDAQ:CYRX) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.000 million-$196.000 million vs $194.390 million estimate.
-
2 months ago benzinga.com
CryoPort Q2 Adj. EPS $(0.20) Misses $(0.19) Estimate, Sales $48.971M Beat $48.207M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 16.67 percent increase over losses of $(0.24)…
2 months ago prnewswire.com
Cryoport Reports Second Quarter 2026 Financial Results
Second quarter revenue grew 8% year-over-year to $49.0 million Life Sciences Services revenue increased 15% year-over-year BioStorage/BioServices revenue grew 25% year-over-year Supporting 779 global…
-
3 months ago benzinga.com
BTIG Maintains Buy on CryoPort, Raises Price Target to $25
BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $17 to $25.
3 months ago prnewswire.com
Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026
NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for…
-
4 months ago benzinga.com
Cryoport’s IntegriCell Cryopreservation Services Selected By Verismo Therapeutics To Support SynKIR-110 And SynKIR-310 Multi-Chain KIR-CAR Programs
IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Services Supporting Verismo's Novel Multi-chain KIR-CAR Programs for Lead Candidates SynKIR™-110 and…
4 months ago prnewswire.com
Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs
IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Services Supporting Verismo's Novel Multi-chain KIR-CAR Programs for Lead Candidates SynKIR™-110 and…
-
5 months ago benzinga.com
Craig-Hallum Maintains Buy on CryoPort, Raises Price Target to $20
Craig-Hallum analyst Matthew Hewitt maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $20.
-
5 months ago benzinga.com
Keybanc Maintains Overweight on CryoPort, Raises Price Target to $17
Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $15 to $17.
-
6 months ago benzinga.com
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $12
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $11 to $12.
-
6 months ago benzinga.com
Needham Maintains Buy on CryoPort, Raises Price Target to $15
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $13 to $15.
-
6 months ago benzinga.com
BTIG Maintains Buy on CryoPort, Raises Price Target to $17
BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $17.
6 months ago seekingalpha.com
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
6 months ago zacks.com
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.22 per share a year ago.
6 months ago benzinga.com
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026'
Cryoport released financial results for Q1 of fiscal 2026 Monday after the closing bell.
-
6 months ago benzinga.com
CryoPort Raises FY2026 Sales Guidance from $190.000M-$194.000M to $192.000M-$196.000M vs $191.834M Est
CryoPort (NASDAQ:CYRX) raises FY2026 sales outlook from $190.000 million-$194.000 million to $192.000 million-$196.000 million vs $191.834 million estimate.
-
6 months ago benzinga.com
CryoPort Q1 Adj. EPS $(0.25) Misses $(0.22) Estimate, Sales $47.800M Beat $44.862M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 10.71 percent increase over losses of $(0.28)…
6 months ago prnewswire.com
Cryoport Reports First Quarter 2026 Financial Results
First quarter revenue grew 16% year-over-year to $47.8 million Commercial cell and gene therapy (CGT) revenue grew 26% year-over-year to $9.1 million, reflecting continued expansion in approved CGT…
6 months ago prnewswire.com
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for…
7 months ago seekingalpha.com
Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven
Cryoport receives a buy rating with a $9.1 price target, implying 17% upside by FY 2026. CYRX demonstrated double-digit revenue growth in Q4 2025, led by Life Sciences Services, and improved gross…
-
7 months ago benzinga.com
Craig-Hallum Initiates Coverage On CryoPort with Buy Rating, Announces Price Target of $15
Craig-Hallum analyst Matthew Hewitt initiates coverage on CryoPort (NASDAQ:CYRX) with a Buy rating and announces Price Target of $15.
7 months ago defenseworld.net
CryoPort, Inc. (NASDAQ:CYRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten brokerages that are presently covering the company, MarketBeat Ratings reports.…
8 months ago benzinga.com
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.
-
8 months ago benzinga.com
Needham Maintains Buy on CryoPort, Raises Price Target to $13
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $13.
8 months ago seekingalpha.com
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
8 months ago zacks.com
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.42 per share a year ago.
8 months ago benzinga.com
CryoPort Q4 Earnings Summary & Key Takeaways
CryoPort Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
CryoPort Q4 Adj. EPS $(0.17) Beats $(0.21) Estimate, Sales $45.450M Beat $42.921M Estimate.
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 17.48 percent. This is a 59.52 percent increase over losses of $(0.42)…
8 months ago prnewswire.com
Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results
FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Sciences Services revenue grew 18% year-over-year in FY 2025, including a 22% rise in…
-
10 months ago benzinga.com
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
1 year ago benzinga.com
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
1 year ago benzinga.com
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday